From: The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis
αFP
HCC Prevalence (%)
PPV (%)
NPV (%)
≥200 ng/ml
10
97.58
93.4
5
95.03
96.7
≥400 ng/ml
95.7
91.86
91.4
95.97
Elevation ≥7 ng/ml/month
98.7
96.92
97.4
98.52